1 / 22

Drug design and testing,

Drug design and testing,. Drug Names. Chemical name- describes its molecular structure and distinguishes it from other drugs. Generic name- is determined by the pharmaceutical company along with the a special organization known as the U.S. Adopted names Council.

Download Presentation

Drug design and testing,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drug design and testing,

  2. Drug Names • Chemical name- describes its molecular structure and distinguishes it from other drugs

  3. Generic name- is determined by the pharmaceutical company along with the a special organization known as the U.S. Adopted names Council

  4. Trade names or brand name- the manufacturer selects alone…can become a registered trademark. They are they only one who can advertise and market the drug under that name.

  5. The particular spelling of a brand name drug is proposed by a manufacture for one of several reasons.

  6. To indicate the disease process being treated • Azmacort- treats asthma • Rythmol- treats cardiac arrhythmias

  7. To simplify the generic name • Pseudoephedrine to Sudefed • Haloperidol to Haldol • Ciprofloxacin to Cipro

  8. To indicate the duration • Slow-K slow release potassium supplement

  9. Drug Design • New drugs are discovered in one of two ways • Totally new chemical substance • Derived from molecular manipulation of a current drug

  10. Drug Design • Until recently,designing a new drug by changing the molecular structure of an existing drug was a very slow process of trial and error

  11. Recombinant DNA technologyGene splicing or genetic engineering • Aided by computer design and use of enzymes, researchers are able to remove DNA chemically from one organism and transplant into other

  12. Testing • In vitro- in glass • In vivo- in living • many guidelines set by FDA

  13. Animal Phase • Precedes human testing • watching for toxic effects,side effects, addictions, cancerous tumors or fetal deformities

  14. Animal Phase • Calculating the Therapeutic Index (TI)…. The difference between the dosage that produces a Therapeutic Effect and the dosage that produces a Toxic Effect

  15. Animal Phase • NOT always a reliable indicator of how well a drug will perform in humans.

  16. Human Testing • 3 phases • 1st phase- Healthy volunteers used to study a safe dose range, evaluate side effects and establish a correct dosage. • Absorption

  17. PhaseII • Drug is given on an experimental basis to patients with the disease it will eventually be used to treat- done to determine the extent of it’s therapeutic effect

  18. Phase III • Drug is administered to several hundreds of ill patients in exactly the way in which it will be used clinically (dosage & route) • compared to other current drugs

  19. Phase III Human • Group A • all patients disorder and receive new drug being studied • results compared to next two groups for side effects and ability to treat disorder

  20. Phase III Human • Group B • all patients have disorder meant to be treated by new drug • all patients receive a placebo and results are compared to other 2 groups

  21. Phase III Human • Group C • all patients have disorder meant to be treated by new drug • patients will be treated by another drug currently being used to treat disorder

  22. FDA Approval • After reviewing all documentation on the safety and effectiveness of the new drug • May be protected by a patent for up to 17 years

More Related